Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 4INDUSTRY 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 20Tumor-Agnostic 6Thoracic 3Other solid neoplasm 3Gastrointestinal 3Gynecologic 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumors 1Advanced Solid Tumors 1

Interventions

Injections 98pembrolizumab 90Carboplatin 57Paclitaxel 54Cisplatin 52Nivolumab 44Docetaxel 43Pemetrexed 42Gemcitabine 37atezolizumab 32tislelizumab 29Bevacizumab 29toripalimab 23Fluorouracil 23Capecitabine 23Irinotecan 22Oxaliplatin 20durvalumab 19Ipilimumab 18Leucovorin 17Cetuximab 17Rifampin 14Itraconazole 14olaparib 13spartalizumab 12Midazolam 12Cyclophosphamide 12trifluridine tipiracil drug combination 11sintilimab 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × ixabepilone × Other solid neoplasm × Clear all
NCT00004927 2017-01-30

BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

R-Pharm

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01018966 2017-01-30

Study of Ixabepilone (BMS-247550) in Patients With Solid Tumors

R-Pharm

Phase 1 Completed
25 enrolled
Other solid neoplasm

Solid Tumors

NCT00632424 2016-03-10

Phase 1 Trial of Oral Ixabepilone

R-Pharm

Phase 1 Terminated
23 enrolled 11 charts
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡